Multiple is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
The best peptides for this category have been ranked based on research evidence, safety profiles, and practical considerations. This guide covers the top compounds with specific dosing protocols and evidence summaries for each.
What Are the Best Peptides for Fat Loss?
This guide ranks the top research peptides for fat loss based on current evidence, safety profiles, and practical considerations.
Each compound below has been evaluated on its mechanism of action, research depth, ease of use, and availability from quality sources.
#1: Ipamorelin — Ipamorelin
Ipamorelin is a Growth Hormone Secretagogue (GHS) / Ghrelin mimetic researched for growth hormone release, improved sleep, fat loss, muscle recovery, bone density support.
Mechanism: Ipamorelin selectively stimulates GH release by mimicking ghrelin at the GHS-R receptor on pituitary somatotrophs. Unlike other GHRPs (GHRP-2, GHRP-6, Hexarelin), it does not significantly increase co
Dosage: 200-300 mcg 2-3 times daily via subcutaneous injection. Cycle: 8-12 weeks, often stacked with CJC-1295.
Why it made the list: The most selective GH secretagogue available — the only GHRP that doesn't meaningfully raise cortisol, prolactin, or appetite at therapeutic doses, making it the safest entry point for GH optimization. Read the full Ipamorelin guide →
#2: AOD-9604 — Fragment 177-191 of Human Growth Hormone (modified)
AOD-9604 is a Lipolytic peptide, GH fragment analog researched for fat loss, increased fat oxidation, improved body composition, joint health support, no IGF-1 elevation.
Mechanism: Activates beta-3 adrenergic receptors in adipose tissue, triggering cAMP-mediated lipolysis and release of stored fat for energy. Suppresses lipogenesis (new fat formation) while promoting fat breakdo
Dosage: 250-1000 mcg daily once daily, ideally morning fasted via subcutaneous injection. Cycle: 12-24 weeks.
Why it made the list: The only GH fragment that selectively targets fat loss without any of growth hormone's effects on blood sugar, insulin, or IGF-1 — making it metabolically clean. The catch is that human efficacy was modest compared to impressive animal data. Read the full AOD-9604 guide →
#3: MK-677 — Ibutamoren Mesylate
MK-677 is a Non-peptide ghrelin receptor agonist, growth hormone secretagogue researched for oral GH elevation (up to 97% increase), lean muscle mass gain, fat loss, improved sleep quality, enhanced recovery, bone density.
Mechanism: Selective non-peptide agonist of the ghrelin receptor (GHS-R1a) that increases GHRH production while simultaneously reducing somatostatin (GH inhibitor). Increases GH pulse amplitude and frequency, pr
Dosage: 10-25 mg daily once daily (usually before bed) via oral. Cycle: 8-16 weeks; minimum 10-week break between cycles.
Why it made the list: The only oral GH secretagogue producing clinically significant GH elevation without injections — uniquely accessible and practical compared to every other peptide that requires subcutaneous administration. Read the full MK-677 guide →
#4: MOTS-C — Mitochondrial ORF of the 12S rRNA Type-C
MOTS-C is a Mitochondrial-derived peptide, metabolic regulator researched for improved insulin sensitivity, glucose metabolism, fat loss, lean muscle preservation, exercise capacity enhancement, anti-aging, metabolic flexibility.
Mechanism: Translocates to the nucleus where it regulates gene expression through the Folate-AICAR-AMPK pathway. Activates antioxidant response elements (ARE) and interacts with NRF2 transcription factor to enha
Dosage: 5-10 mg per week 2-3 times weekly via subcutaneous injection. Cycle: 8-12 weeks with 8-12 week breaks.
Why it made the list: The first mitochondrial genome-encoded peptide to enter human testing — essentially exercise in a peptide, activating the same AMPK pathways triggered by physical training. Read the full MOTS-C guide →
#5: Sermorelin — Growth Hormone-Releasing Hormone analog (GRF 1-29)
Sermorelin is a GHRH analog, growth hormone secretagogue researched for endogenous GH stimulation, lean mass gain, fat loss, IGF-1 elevation, improved recovery, bone density.
Mechanism: Binds GHRH receptors on anterior pituitary somatotrophs, activating cAMP-PKA signaling to stimulate GH synthesis and pulsatile secretion. Preserves natural GH feedback mechanisms — unlike exogenous GH
Dosage: 200-500 mcg daily once daily before bedtime via subcutaneous injection. Cycle: 12-24 weeks; adjust after 4-6 weeks based on IGF-1 levels.
Why it made the list: The only GHRH analog that preserves natural pulsatile GH secretion and feedback mechanisms — stimulates your body's own GH production rather than injecting exogenous hormone. Read the full Sermorelin guide →
Can You Combine Multiple Fat Loss Peptides?
Stacking complementary peptides for fat loss is a common research approach. The key is combining compounds with different mechanisms to target multiple pathways without overlapping side effects.
See our stacking and cycling guide for principles on combining peptides safely.
How to Get Started
For beginners, start with a single, well-researched peptide rather than a complex stack. Use our dosing calculator for reconstitution math and our beginner's guide for step-by-step instructions.
Source from vendors with third-party COA testing — quality is the most important factor in achieving consistent research results.
Research-Grade Sourcing
If you're going to research Multiple, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is Multiple?
Multiple (Multiple) is a research peptide. Synthetic peptide. It is researched for various applications.
What is the recommended Multiple dosage?
Common dosages: varies administered per protocol via subcutaneous injection. Cycle length: 4-12 weeks. Half-life: varies. Use our peptide calculator for exact reconstitution math.
What are the side effects of Multiple?
Limited safety data available. Potential injection site reactions and individual sensitivity. No serious adverse events documented in available literature.
Is Multiple safe?
Multiple has shown a preliminary safety profile in research. Not FDA-approved. Available as a research chemical in most jurisdictions. All research should follow appropriate safety protocols.